WO2024218193 - METHODS FOR IMPROVING INDIVIDUAL SERIAL DIAGNOSTIC TESTING

National phase entry is expected:
Publication Number WO/2024/218193
Publication Date 24.10.2024
International Application No. PCT/EP2024/060497
International Filing Date 18.04.2024
Title [English] METHODS FOR IMPROVING INDIVIDUAL SERIAL DIAGNOSTIC TESTING [French] PROCÉDÉS POUR AMÉLIORER DES TESTS DIAGNOSTIQUES INDIVIDUELS EN SÉRIE
Applicants ** RANDOX LABORATORIES LTD Ardmore 55 Diamond Road Crumlin Antrim BT29 4QY, GB
Inventors ** INNOCENZI, Paul John Randox laboraories Ltd Ardmore 55 Diamond Road Crumlin Antrim BT29 4QY, GB FITZGERALD, Stephen Peter Randox Laboratories ltd Ardmore 55 Diamond Road Crumlin Antrim BT294QY, GB MCCONNELL, Ivan Randox Laboratories ltd Ardmore 55 Diamond Road Crumlin Antrim BT294QY, GB
Priority Data 2305864.7  21.04.2023  GB
front page image
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 1062
EPO Filing, Examination 4708
Japan Filing 575
South Korea Filing 579
USA Filing, Examination 2635
MasterCard Visa
Total: 9559
Abstract [English] A method of supporting diagnostic decisions based on biochemical measurements is presented. The use of a correction factor derived from population biochemical measurement values when applied to a follow-on biochemical measurement value of an individual mitigates pre-analytical and analytical variation enabling more robust clinical analyses and decisions to be made. [French] L'invention concerne un procédé d'aide aux décisions diagnostiques sur la base de mesures biochimiques. L'utilisation d'un facteur de correction dérivé de valeurs de mesure biochimique de la population, lorsqu'il est appliqué à une valeur de mesure biochimique de suivi d'un individu atténue les variations pré-analytiques et analytiques, ce qui permet d'effectuer des analyses cliniques et de prendre des décisions cliniques plus solides.